8 research outputs found

    Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

    Get PDF
    Supported by F. Hoffmann–La Roche

    Modified ZSM-5 catalysts for the synthesis of five- and six-membered heterocyclic compounds

    No full text
    This article does not have an abstract

    Acquired Neurological Disorders and Diseases of Childhood

    No full text

    Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

    No full text
    Background Rosiglitazone is a thiazolidinedione that reduces insulin resistance and might preserve insulin secretion. The aim of this study was to assess prospectively the drugs ability to prevent type 2 diabetes in individuals at high risk of developing the condition

    Tropospheric Ozone and Plants: Absorption, Responses, and Consequences

    No full text
    corecore